Study: Enspectra Health’s Cross-modal Technology Delivers Histological Insights Noninvasively
Enspectra Health’s U.S. Food and Drug Administration (FDA) cleared non-invasive cross-modal imaging technology (VIO System) provides real-time visualization of skin cellular structure and composition, according to research in Scientific Reports. Portable and handheld, cross-model imaging digitizes histopathology directly from a patient’s skin to provide actionable health insights for dermatologists – without biopsy. The publication outlines […]